Table 2.

Updated/started Cochrane reviews as a result of NIHR HTA Grant (14/27/02) [49]

Anticholinergic medication for antipsychotic-induced tardive dyskinesia [53]

Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia [54]

Benzodiazepines for antipsychotic-induced tardive dyskinesia [55]

Calcium channel blockers for antipsychotic-induced tardive dyskinesia [56]

Cholinergic medication for antipsychotic-induced tardive dyskinesia [57]

Gamma-aminobutyric acid agonists for antipsychotic-induced tardive dyskinesia [58]

Miscellaneous treatments for antipsychotic-induced tardive dyskinesia [59]

Non-antipsychotic catecholaminergic drugs for antipsychotic-induced tardive dyskinesia [60]

Pyridoxal 5 phosphate for neuroleptic-induced tardive dyskinesiaa [61]

Vesicular monoamine transporter inhibitors versus placebo for antipsychotic-induced tardive dyskinesiab [62]

Vitamin E for antipsychotic-induced tardive dyskinesia [63]

^aThis review is absent in the published report [51] because there was no new study

^bThis review is absent in the published report [51] because we became informed and started this review as a result of update search process in SBR